B&C News: Endocrine Disruptors

January 6, 2023
Bergeson & Campbell, P.C. Releases 2023 Forecast for U.S. Federal and International Chemical Regulatory Policy
Bergeson & Campbell, P.C. (B&C®) and its global consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to offer you our Forecast 2023, our seasoned team’s collective take on what to expect regarding global industrial, agricultural, and biocidal chemical initiatives in the New Year. We have worked hard to offer our best-informed judgment on the trends and key developments we expect to see in 2023. Here at home, most would agree the Biden Administration has made bold and consequential ... read more >
January 3, 2022
Bergeson & Campbell, P.C. Releases 2022 Forecast for U.S. Federal and International Chemical Regulatory Policy
Bergeson & Campbell, P.C. (B&C®) and its consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to offer you our Forecast 2022. The extraordinary diversity and complexity of global industrial, agricultural, and biocidal chemical initiatives in which our clients engage are reflected in the detailed summary that follows, prepared by the legal, scientific, and regulatory professionals of B&C, Acta, and BCCM. In this comprehensive overview, we offer our best informed judgment as to the trends ... read more >
September 14, 2021
Lynn L. Bergeson Quoted in Chemical Watch Article “EPA’s timeline to rework TSCA PBT rules ‘impossible to justify’, NGOs say”
On September 14, 2021, Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C. (B&C®), was quoted by Chemical Watch regarding criticism of the U.S. Environmental Protection Agency’s (EPA) decision to grant industry additional time to comply with a Toxic Substances Control Act (TSCA) prohibition on phenol, isopropylated phosphate (3:1) – or PIP (3:1) – in articles.  Some in industry, however, argue the approach represents the agency’s best effort in a tricky situation.  Lynn Bergeson, managing director at Bergeson & ... read more >
January 15, 2020
Bergeson & Campbell’s Forecast 2020
This week, I sat down with my colleagues Sheryl Lindros Dolan, Chris Bryant, and Dr. Richard Engler to discuss our fabulous 2020 Forecast, B&C’s and The Acta Group’s (Acta®) richly detailed overview of key trends in U.S. and global chemical law and policy. This 67-page document provides a comprehensive “one-stop” overview of global initiatives for the New Year of which stakeholders in the global chemical market must be aware. My colleagues provide a spirited overview of key developments, speculate on the impact of the U.S. general elections later this year, ... read more >
April 15, 2019
Jason E. Johnston, M.S. Co-Authors “Benchmarking the Current Codex Alimentarius International Estimated Short-Term Intake Equations and the Proposed New Equations” in the Journal of Agriculture and Food Chemistry
Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce the publication of “Benchmarking the Current Codex Alimentarius International Estimated Short-Term Intake Equations and the Proposed New Equations,” co-authored by Jason E. Johnston, M.S., Senior Scientist with B&C and Acta. The article was published by the Journal of Agriculture and Food Chemistry and can be accessed at http://pubs.acs.org/doi/abs/10.1021/acs.jafc.8b05547.  The five co-authors of the study were assembled by Cheryl Cleveland through CropLife ... read more >
August 3, 2017
Heather F. Collins, M.S., Joins Bergeson & Campbell, P.C. and The Acta Group
Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Heather F. Collins, M.S., has joined our firms as a Regulatory Consultant.  Ms. Collins has nearly two decades of experience developing, implementing, and managing environmental, health, and safety (EH&S) compliance for global chemical and chemical product companies.  Her prodigious skills in developing biocide and pesticide registration and compliance strategies, safety data sheet (SDS) authoring, and dangerous goods management, coupled with her keen awareness of the ... read more >
January 11, 2017
The Top Chemical Regulatory Stories of 2016
  The attorneys, scientists, policy experts, and regulatory advisors of Bergeson & Campbell, P.C. (B&C®), The Acta Group (Acta®), and B&C® Consortia Management, L.L.C. (BCCM) endeavor year-round to keep you informed on key developments as they happen, and prepared for looming changes and deadlines, to help you maintain compliance and competitive advantage as you market your products throughout the world. As the new year begins, we offer you this look back at the top stories of 2016 (as measured by clicks, reads, and shares by readers of our blogs and e-mails), a ... read more >
September 4, 2013
EDSP Testing Consortia Forming Now to Meet EPA’s Deadline
B&C® Consortia Management, L.L.C. (BCCM) is assisting companies with forming testing consortia to fulfill regulatory requirements under the U.S. Environmental Protection Agency's (EPA) Endocrine Disruptor Screening Program (EDSP). On June 14, 2013, EPA issued the final second list of chemicals and substances for Tier 1 screening under the EDSP. Our memorandum regarding this development is provided below. EPA has indicated that it will issue test orders for the Group 2 chemicals in batches, with the first batch to be issued as early as September 2013. The EDSP has an ... read more >
April 23, 2012
Interim Guidance Sets Standards for Offers to Pay for Use of Endocrine Program Data
The April 23, 2012, issue of Bloomberg BNA Daily Environment Report quotes Lynn L. Bergeson concerning an interim guidance developed by the U.S. Environmental Protection Agency (EPA) that outlines the elements of an offer to pay for the use of inert ingredient data used to meet test orders under the Endocrine Disruptor Screening Program ... read more >
October 28, 2011
As First EDSP Test Deadline Nears, EPA Faces Host of Industry Concerns
The October 28, 2011, issue of Inside EPA quotes Bergeson & Campbell, P.C.’s October 4, 2011, memorandum regarding the U.S. Environmental Protection Agency’s final guidance on the weight-of-evidence (WoE) analysis that it will use to evaluate the results of data submitted in response to test orders issued for Tier 1 screening under the Endocrine Disruptor Screening Program ... read more >

 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2023 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.